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ABSTRACT
A novel method of spontaneous generation of new adipose tissue from an existing fat flap is described.
A defined volume of fat flap based on the superficial inferior epigastric vascular pedicle in the rat was
elevated and inset into a hollow plastic chamber implanted subcutaneously in the groin of the rat. The
chamber walls were either perforated or solid and the chambers either contained poly(D,L-lactic-co-glycolic
acid) (PLGA) sponge matrix or not. The contents were analyzed after being in situ for 6weeks. The total
volume of the flap tissue in all groups except the control groups, where the flap was not inserted into the
chambers, increased significantly, especially in the perforated chambers (0.08 ± 0.007mL baseline com-
pared to 1.2 ± 0.08mL in the intact ones). Volume analysis of individual component tissues within the flaps
revealed that the adipocyte volume increased and was at a maximum in the chambers without PLGA,
where it expanded from 0.04 ± 0.003mL at insertion to 0.5 ± 0.08mL (1250% increase) in the perforated
chambers and to 0.16± 0.03mL (400% increase) in the intact chambers. Addition of PLGA scaffolds
resulted in less fat growth. Histomorphometric analysis rather than simple hypertrophy documented an
increased number of adipocytes. The new tissue was highly vascularized and no fat necrosis or atypical
changes were observed.
INTRODUCTION
THE RECONSTRUCTION OF SOFT-TISSUE DEFECTS followingoncologic resections, complex trauma, or hereditary and
congenital malformations still presents a major challenge in
plastic and reconstructive surgery. Soft tissue, largely com-
posed of subcutaneous adipose tissue, plays a major role
in maintaining the contours and cosmetic appeal, and also
serves as a mechanical cushion for muscles, tendons, and
bones.1 To date, local and free flaps, dermal fat grafts, col-
lagen injections, synthetic materials such as silicone, and
free adipose tissue grafts are used for reconstruction of soft-
tissue defects. All these have disadvantages and limita-
tions.2 Synthetic materials can cause foreign body reactions
and infections, while biologically derived materials tend to
resorb to an unpredictable extent.3 Autologous adipose tis-
sue should be an ideal graft material as there is ample sup-
ply, but the results of free grafting are generally poor and
unpredictable.4 Some studies report that almost all of the
grafted tissue is resorbed and replaced by fibrous tissue and
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oil cysts,5,6 possibly due to insufficient revascularization and
the low ischemic tolerance and high metabolic rate of fat
cells.7,8 The injection of aspirated fat fragments also yielded
unsatisfactory results, ranging from 50% shrinkage of the
graft to complete resorption.4,9 Yuksel and colleagues10
were able to increase survival of free fat grafts with growth
factor loaded microspheres. An autologous vascularized
adipose tissue construct, due to its intrinsic blood supply,
would have considerable advantage over conventional adi-
pose tissue grafts for reconstruction of large soft-tissue de-
fects.11 Unfortunately, there are only limited donor sites for
large vascularized fat flaps, and donor-site secondary mor-
bidity cannot be excluded.
We have ‘‘grown’’ nonspecific granulation tissue flaps
spontaneously in vivo inside a chamber space by implanting a
vascular loop or pedicle into the chamber together with a
collagen matrix.12 New vascular growth derived from the
pedicle invaded the matrix progressively, together with in-
flammatory and fibroblastic cells, to produce a fibrous tissue
flap,which inmany cases filled the chamber.When the cham-
ber space was enlarged, tissue growth increased,13 suggesting
that the maintenance of a potential space played a role in
driving the growth process. Tanaka et al. have demonstrated
that if perforations are made in the walls of the chambers to
permit communication from outside, tissue growth could be
enhanced.12 When a small piece of free muscle tissue was
added to this same rat chamber model, the muscle induced
spontaneous fat formation.14 In a mouse model we have also
spontaneously produced fat inside a chamber by the addition
of Matrigel.15 Matrigel is an extracellular matrix extract
with adipogenic properties, but unfortunately is incompatible
with humans as it is derived from a mouse sarcoma.
An engineered adipose tissue construct with its own
blood supply would have the potential to circumvent many
of the current limitations of large-volume adipose tissue
grafting. Using our experience with spontaneous growth of
tissue flaps in chambers, we aimed in this study to engineer
expanded volumes of adipose tissue utilizing a rat chamber
model incorporating a small amount of vascularized adipose
tissue on a pedicle. It was hypothesized that the chamber
space and its environment would encourage growth and
survival of the adipose tissue along with neovascularization
from the pedicle. The effects of adding a poly(D,L-lactic-co-
glycolic acid) (PLGA) matrix in the chamber and of mul-
tiple perforations in the chamber walls were also tested. We
showed, for the first time, that significant amounts of fat
tissue can be grown spontaneously inside an enclosed cham-
ber space without the need for cell implantation, growth
factors, or matrix material.
MATERIALS AND METHODS
Animals
Adult male Sprague-Dawley rats weighing 350 to 400 g
were used for this study. All rats were housed on a 12-hour
light/dark schedule, and received a stock diet and water ad
libitum. All experiments described were approved by the
Animal Ethics Committee of St. Vincent’s Hospital, Mel-
bourne, and were conducted according to the guidelines of
the National Health and Medical Research Council (NH &
MRC; Australia).
Tissue engineering chambers
Polycarbonate chambers were manufactured by the De-
partment of Chemical and Biomolecular Engineering, Uni-
versityofMelbourne,Australia.Thehemispherical chambers
have an internal diameter of 18mm; the flat base and a
dome-shaped lid clip together form a 1.7mL chamber with a
dome height of 8mm. The base has four suture holes, which
allow the chamber to be anchored to surrounding tissues. An
opening in the wall, occupying 15% of the circumference,
allows for entry of the vessels. Two different chamber de-
signs, intact and perforated, were used, with holes of 2mm
diameter drilled into the walls.
PLGA scaffolds
Custom-made three-dimensional (3D) 75/25 PLGA scaf-
folds were manufactured in the Department of Chemical and
Biomolecular Engineering, University of Melbourne, using
the thermally induced phase separation (TIPS) technique.16,17
The TIPS scaffolds, with an open and interconnected struc-
ture, are much more porous than the conventional salt-
leached scaffolds. The pores are approximately 450 (m in the
center and become radially smaller, approaching 20mm in the
periphery. Scanning electron microscopy (XL 30, Philips,
Netherlands) with a LaB6 electron gun operated at 20 kVwas
used to evaluate the macro/micro porous structures of the 3D
PLGA scaffolds, allowing quantification of pore size, pore
shape, structural alignment, and interconnectivity. Prior to
in vivo insertion, the scaffolds were sterilized with 100%
alcohol for 30 seconds, followed by three 30-minute washes
in sterile phosphate buffered saline.
Experimental design
Control group 1: A vascularized adipose tissue flap of
standardized dimensions (851.5mm) and based on the
superficial inferior epigastric vessels was dissected in situ.
It was immediately removed from the animal and volu-
metrically and morphologically assessed. This group re-
presented the normal fat tissue at day 0 and served as the
baseline control against which flap growth and morpho-
logical change were assessed (n¼ 8). All other flaps were
measured and trimmed to this size when created for all
other experimental groupings (Fig. 1).
Control group 2: Flaps were dissected on their vascular
pedicles and left in situ in the subcutaneous tissue of the
groin with no chamber and no scaffold (n¼ 6 flaps).
Group 3: Flap in a closed chamber without PLGA scaf-
fold (n¼ 5 chambers).
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Group 4: Flap in a closed chamber with PLGA scaffold
(n ¼ 5 chambers).
Group 5: Flap in a perforated chamber without PLGA
scaffold (n¼ 6 chambers).
Group 6: Flap in a perforated chamber with PLGA
scaffold (n¼ 6 chambers).
The chambers were inserted bilaterally with an intact
chamber on the right side and a perforated chamber on the
left (either with or without a PLGA scaffold). In groups 2–6
the in vivo incubation time of the pedicled vascularized
adipose tissue flaps was 6weeks.
Insertion of the chambers
All surgical procedures were performed under aseptic
conditions. Intraperitoneal anesthesia was administered
using 60mg/kg sodium pentobarbital (Nembutal, Abbott,
Chicago, IL). The animals were placed in a supine position,
shaved, and scrubbed with ethanol. The superficial inferior
epigastric vessels on both sides of each animal were dis-
sected from the groin along the axis of the milk line of the
animal and the associated fat stripped along the length of the
pedicle with a small (851.5mm) adipose tissue flap left
at the end. The distal end of the pedicle was ligated and
divided. All fascial attachments were divided, and the flap
was elevated in an island fashion. The flap’s surface was
painted lightly with India ink, and then sandwiched hor-
izontally between two PLGA scaffolds if used (groups 4 and
6). In groups 3 and 5 the adipose tissue flap was inserted into
the chamber without a scaffold. The lid of the chamber was
closed and the chamber was secured beneath the inguinal
skin with three 6-0 Prolene holding sutures. In control group
2, the adipose tissue flap was labeled on the boundaries with
nonabsorbable 8-0 sutures and India Ink and replaced in the
dissected area without scaffold or chamber. The wound was
closed with 4-0 silk sutures. All animals tolerated the cham-
ber implantation without complication.
Tissue harvest
After 6weeks the rats were reanesthetized, both inguinal
regions opened, and the superficial inferior epigastric ped-
icles visually assessed for patency. Blood flow through the
pedicle was clearly visible during dissection, and a light
pressure was applied using forceps to assess flow. The con-
tents of the chamber were removed for volumetric and
morphological analysis. Animals were sacrificed under an-
esthetic by intracardiac administration of pentobarbitone
sodium (3mL of 325mg/mL solution).
Tissue assessment and processing
The harvested tissue flap constructs were weighed and
their total volume measured by fluid displacement. For this,
the tissue was suspended using a fine cotton suture thread
and entirely immersed in a beaker of saline on a balance. The
volume was calculated assuming a density of 1 g/mL.18 The
specimens were cut serially into sagittal sections 1mm thick
and fixed in 10% buffered formalin. A Nikon Coolpix 995
digital camera was used to capture high-resolution digital
images of the sections. Alternate sections were embedded in
paraffin, and cut sections (5 mm thick) were stained with
hematoxylin & eosin, Mason’s trichrome, and toluidine blue
for histology to determine the formation of new adipose
tissue and generation of blood vessels. Histomorphometric
assessment of the percentage volume of each component
(connective tissue, adipose tissue, pedicle blood vessels, and
PLGA/space) was done using a microscope (Olympus BH-2
RFCAmicroscope, Olympus Denmark, Glostrup, Denmark)
with a20 objective making use of an established point
counting method19 and fitted stereological software (CAST
2, Olympus Denmark). PLGA/space is defined as the
unstained space in the tissue where thin cross sections of
FIG. 1. Gross morphology of the fat flap prior to and after in-
sertion into the chamber. (A) Dissection of the vascular pedicle
and associated fat flap. (B) Insertion of the fat flap into a perfo-
rated chamber. Flap is resting on the base of the chamber, with the
domed lid behind it. (C) Harvest of tissue out of the chamber after
6weeks. (D) Cross section of chamber showing bolus of fat tis-
sue surrounded by capsule. (E) Cross sections of harvested tissue
showing fat and remnants of PLGA scaffold. (F) Harvest of tissue
from flaps not placed in chamber. The total tissue volume is
clearly smaller than that harvested from the chamber at the same
time point, compared to (C). Scale bars¼ 5mm.
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residential PLGA can be seen, as PLGA does not absorb
routine histological stains (Cao et al. 2005 submitted). The
percentage volumes were calculated by dividing the per-
centage of the total volume occupied by the respective field
with the total volume of the tissue construct. Tissues were
point counted by two independent observers, using a com-
puter generated grid. An average of 200 points per construct
were counted depending on the size of the sample. Samples
were counted under high magnification (200) so that cell
and tissue types could be readily identified.
Statistical analysis
Percentage volume changes of the tissue over time were
analyzed for significance using a two-way ANOVA (SPSS,
SPSS Inc., Chicago, IL), with a value of p< 0.05 regarded
as statistically significant. Values are presented as mean
standard error.
RESULTS
Gross morphology and flap volume
Inspection of the construct implantation site showed no
significant inflammation or tissue necrosis. A small amount
of seroma had accumulated around three chambers. All ad-
ipose tissue flaps in all groups appeared viable and well
perfused and were surrounded by a capsular layer of con-
nective tissue. The volume of the tissue flaps in all chamber
groups increased. The flaps in the perforated chambers (Fig.
1C, D) (groups 5 and 6) were larger than those in the intact
chambers (groups 3 and 4, p< 0.001, Table 1), increasing
from 0.08 0.002mL to 1.21 0.08mL without PLGA and
to 1.31 0.1mL with PLGA. In the perforated chambers,
the tissue formed connections with the vascularized extra
capsular tissue outside the chambers through the perforations
(Fig. 1C). As a result, all of the perforated chambers ap-
peared filled with flap tissue. However, there was some re-
traction away from the chamber once these connections were
separated. There was little difference between the volume of
the tissues in control group 2 (no chamber) and those in
control group 1, which represented the dissected flap at in-
sertion into the chamber at T¼ 0 (Fig. 1A, F)
Point counting of tissue components
The mean volume of adipocytes in the adipose tissue flap
at insertion was 0.041 (0.001)mL. In control group 2,
where there was no chamber or scaffold around the dis-
sected vascularized adipose tissue flap, the volume of adi-
pocytes remained at 0.04 0.02mL after 6weeks in vivo.
In the closed chambers without PLGA (group 3), the adi-
pose component of the tissue flap increased significantly to
a volume of 0.16 0.07mL, an increase of 400%. In the
perforated chambers without PLGA (group 5), the volume
increased to 0.485 0.08mL, an increase of 1250% com-
pared to the insertion volume at T¼ 0. These results repres-
represent an exponential increase in the adipose tissue
growth in 6weeks. The use of a PLGA scaffold produced
significantly less adipocyte growth in the closed (0.05
0.03mL or 8% total tissue volume in chambers with PLGA
vs. 0.16 0.07mL or 35% total tissue volume without) as
well as perforated (0.234 0.063mL or 18% total tissue
volume with PLGA vs. 0.485 0.08mL or 40% total tis-
sue volume without) chambers at 6weeks after implanta-
tion ( p< 0.002). The differences between the closed and
perforated chamber models were statistically significant
( p< 0.001) (Fig. 2).
A qualitative histomorphometric assessment of the vas-
cularized adipose tissue suggested that a similar adipocyte
size distribution could be found in all study groups. Table 1
gives a breakdown of the tissues analyzed by point counting,
showing the percentagevolumeof each tissue type counted—
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FIG. 2. Total tissue and fat tissue volumes from harvested tissue
at 6weeks. Data is expressed in mean standard error.
TABLE 1. BREAKDOWN OF VOLUMES OF THE VARIOUS TISSUE TYPES IN THE FAT FLAP CONSTRUCTS
Connective tissue Adipocytes Blood vessels Gland PLGA/space
Day zero 0.03mL (34%) 0.04mL (48%) 0.01mL (13%) 0.004mL (5%) 0
Control no chamber 0.07mL (54%) 0.03mL (25%) 0.01mL (10%) 0.01mL (10%) 0
Intact chamber no PLGA 0.23mL (52%) 0.16mL (35%) 0.02mL (6%) 0.03mL (7%) 0
Intact chamber with PLGA 0.38mL (62%) 0.05mL (8%) 0.02mL (4%) 0.02mL (4%) 0.14mL (22%)
Perforated chamber no PLGA 0.64mL (53%) 0.48mL (40%) 0.04mL (3%) 0.04mL (4%) 0
Perforated chamber with PLGA 0.75mL (57%) 0.2mL (18%) 0.05mL (6%) 0.04mL (3%) 0.23mL (17%)
The percentages of each tissue component (shown in brackets) appear to remain constant in each group, except that the addition of PLGA does not
encourage the growth of adipose tissue.
676 DOLDERER ET AL.
connective tissue, adipose tissue, blood vessel (arteriovenous
loop), and breast (gland). Control group 1, which represented
the vascularized adipose tissue at day 0, showed mature fat
tissue with supporting blood vessels and connective tissue.
The adipose tissue contained epithelial tissue spots, which
were composed of tubular glands arranged in lobules with
the appearance of breast tissue and represented 1 to 13%
(mean of 5.2%) of the total tissue. This can be expected as the
adipose tissue flap was taken from the groin along the milk
line of the animal.
In the chamber groups with no PLGA scaffold (groups 3
and 5) two components were present: a tissue capsule en-
circling the fat tissue, and a mature adipose tissue as the
main central component (Fig. 3C, G). All tissues appeared
viable with no areas of fat necrosis. Adipocytes were of
normal size, and no signs of atrophy or gross hypertrophy
were found (Fig. 3D, E, H, J). The adipose tissue flap had a
normal vascular architecture. The breast epithelial com-
ponent of the flap remained in proportion to that at T¼ 0
and otherwise showed no pathological changes. The cap-
sule comprised immature tissue with vessels arranged hap-
hazardly (Fig. 3B) and having vascular communications
with the underlying adipose tissue.
In the intact chamber (groups 3 and 4) the volume of the
vascularized adipose tissue increased. Fat cells were ma-
ture and of normal size, blood vessels were normal, and there
were no signs of atrophy or hypertrophy of adipocytes. The
adipose tissue showed no fibrosis and the epithelium com-
ponent remained in normal proportions.
In the perforated chambers (groups 5 and 6), the con-
nective tissue passed through the perforations with in-
growing vessels. In addition, the connective tissue around
the flap appeared to be thicker and more vascular than that
in the closed chamber. In some focal areas some vessels
from the capsule extended into the underlying adipose tis-
sue The adipose tissue showed no signs of necrosis, atro-
phy, or hypertrophy. The epithelial component stayed in
proportion to the original adipose tissue.
In the groups with the PLGA scaffold (groups 4 and 6),
the growth pattern of the vascularized adipose tissue seemed
to be similar, except for the layer of remaining vascularized
PLGA scaffold between the adipose tissue and the thicker
layer of connective tissue on the periphery (Fig. 3E, F, I, J).
There was some blood vessel ingrowth into the scaffold,
from both the capsule and the adipose tissue. There was
also foreign body reaction in the scaffold. At 6weeks there
was no evidence of adipocyte ingrowth into the scaffolds,
probably because the adipocytes were larger than the pores
of the remaining scaffolds. In contrast to groups 3–6, the
control group 2, which had no chamber or scaffold, exhi-
bited no obvious expansion or growth despite a similar
gross morphology (Fig. 3A, B). In addition, there was no
difference in adipocyte morphology compared to day 0 and
no sign of adipocyte necrosis, atrophy, or hypertrophy. The
epithelial component remained unchanged with no obvious
excess growth.
FIG. 3. Histology sections fromeachgroup, showing the sizeof the
constructs and the newly developing tissue. (A) Section from group
2 showing the fat flap left in situ for 6weeks without a chamber.
Construct is smaller than in other groups and shows the fat flap sur-
rounded by vascular connective tissue. (B) High-power section from
group 2 showing some adipose tissue, but predominantly vascular
connective tissue. (C) Group 3 construct (intact chamber/no PLGA)
taken at same magnification as (A), showing the increase in size
compared to group 2 constructs and the increase in adipose tissue. (D)
Higher-powered image showing the new, healthy vascularized adi-
pose tissue. (E) Group 4 construct (intact chamber/PLGA). The ad-
ipose tissue has increased to a lesser extent, and while the chamber is
larger than in group 2 samples, there ismore connective tissue present
as the adipose tissue has not entered the PLGA. (F) Adipose tissue
adjacent to the connective tissue/PLGA space region. (G) Group 5
construct (perforated chamber/no PLGA) showing that the size of the
constructs has increased further and that the chamber is filling upwith
adipose tissue, surrounded by a smaller band of connective tissue/
capsule than in previous groups. (H) Well-vascularized new adipose
tissue growing in the construct. (I) Group 6 construct (perforated
chamber/PLGA) showing increased construct size and increased
adipose tissue, which has pushed away the PLGA to expand. (J) The
PLGA has been filled with vascularized connective tissue as per
group 4, with new adipose tissue growing near the edge of the PLGA.
Scale bars¼ 1000mm (LP) or 100mm (HP), ff¼ fat flap, adi¼
adipose tissue, cap¼ capsule, ped¼ pedicle, c/p¼ connective tissue/
PLGA. Color images available online at www.liebertpub.com/ten.
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DISCUSSION
This study demonstrates that significant amounts of adi-
pose tissue can be produced by simply inserting a quantum of
vascularized fat into a chamber space. Tissue growth is spon-
taneous and needs no additional cells, growth or differentia-
tion factors, or extracellular matrices. The tissue thus formed
is autologous so that there are no issues with immunity, and it
develops around a preexisting vascular pedicle, which itself
expands and grows to support the proliferating adipocytes
and permits transfer to distant sites. This model has the po-
tential to act as a support structure for the addition of other
autologous cells, as the existing fat tissue offers support in the
form of vascularization and endogenous growth factors.
Current approaches to restore or augment adipose tissue
volume include synthetic implants or autologous fat graft-
ing, usually by injection. Unfortunately, autologous adipose
tissue grafts lose up to 60% of their volume after trans-
plantation4–6 due to insufficient initial blood supply.7,8 This
is not surprising, considering the critical role that vascu-
larization plays in the survival of transplanted cells. There-
fore, vascularized autologous adipose tissue grafts have
considerable advantages over conventional fat grafts for
reconstruction of large defects, because the blood supply is
intrinsic to the graft.18,19 However, large vascularized adi-
pose tissue grafts have limited donor sites and harvest may
produce donor-site deformity and morbidity.20–22
Over the last decade, tissue engineering has emerged as a
multidisciplinary field focused on the development of func-
tional constructs from living tissue, with the potential to
provide surgeons with patient- and type-specific tissue sam-
ples.8 There are a number of prototypes of skin, cartilage,
bone, blood vessels, and other organs in the biomedical land-
scape with some making their way to commercial products.
The major hurdle all engineered constructs must overcome
is the growth and maintenance of a permanent blood supply
to provide nutrients and oxygen and to remove cellular
waste. Current strategies for in vivo engineering of adipose
tissue have pursued two general pathways: culture of iso-
lated preadipocytes and subsequent transfer to the tissue
site,21,23–26 or de novo adipose tissue formation induced by
altering the tissue microenvironment to recruit resident
preadipocytes.8,15,27,28
In studies with cultured preadipocytes implanted in a
well-vascularized environment and under precisely con-
trolled conditions, it was shown that the cells will expand
and differentiate in vivo.29 Unfortunately, the translation of
this precultured method to the animal model is problematic.
For example, preadipocytes seeded onto a biodegradable
polymer (PLGA) scaffold underwent differentiation, but the
newly formed adipose tissue disappeared when the scaffold
was degraded.23 Vascular support of the construct is likely to
be one of the most important, if not the most critical, factors
limiting the size and quality of the engineered tissue.
Successful reports of de novo adipogenesis involved
basement membrane components (Matrigel) and/or exog-
enous growth factors, but the size of the fat constructs are
relatively modest.15,27,28,30,31 There are no data available
regarding long-term stability without exogenous growth
factors. Whether the matrix is merely acting as a sump for
the maintenance of growth factors32 or has intrinsic adi-
pogenic roles is not clear. Yuksel and colleagues33 have
been able to augment inguinal adipofascial flaps de novo
based on a vascular pedicle. But this was achieved only
when the adipofascial flap was surrounded by a combina-
tion of biodegradable PLGA microspheres loaded with
adipogenic and angiogenic growth factors to accelerate the
differentiation process.
Our current understanding of the mechanisms regulating
adipogenesis is still relatively limited, but there is consider-
able evidence that adipocyte differentiation and prolifera-
tion involve a complex series of interactions integrally
related to angiogenesis.34–39 Endothelial cells have been
shown to promote preadipocyte proliferation and differen-
tiation during adipogenesis.40–42 Conversely, mature adi-
pose tissue is pro-angiogenic, primarily due to its secretion
of growth factors and hormones.43,44
In our present study we grew large volumes of histolog-
ically mature adipose tissue without precultured cell seed-
ing, exogenous angiogenic or adipogenic growth factors, or
extracellular matrices. Some or all of these elements have
been essential to the success of all previous methods of fat
production. Essential to the success of our model of new
tissue growth and expansion is the implantation of the
vascular pedicled flap into a protected space created by the
rigid noncollapsible chamber. In group 2, where the flap
remained outside the chamber, a minimal amount of new fat
grew. It has been shown previously in prefabrication stud-
ies45 as well as in studies using tissue engineering cham-
bers12 that the vascular pedicle induces intense angiogenic
sprouting and fosters implanted cell survival.46 Also, in-
creasing the volume of the chamber increases the volume of
tissue produced.13 In this study, the neo-angiogenesis ap-
pears conducive to adipogenic proliferation.
Cell and cell-cell behavior are influenced by extra- and
intracellular mechanical forces, which by a process of
mechanotransduction transmit intracellular signals to the
nucleus, influencing cell migration, proliferation, differen-
tiation, and apoptosis.47–50 Proliferating tissues within a
protected chamber cavity are subjected to altered mechan-
ical forces compared to those in normal environments.
These microanatomical changes to the cells may explain the
adipose tissue volume increases observed within the cham-
bers.51 Comparison of the closed and perforated chambers
suggests that the perforations improved the contact with,
and the supply of nutrients from, the environment outside
the chamber. This apparently favored additional angiogenic
invasion from the outside and maximized the vascular net-
work in the chamber tissue by linking with the intrinsic
vascular supply. This improved vascularization may have
stimulated adipose tissue growth. The connective tissue in-
vades from the exterior through the perforations in the
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chamber wall and forms guy-rope-like connections with the
intrachamber tissue and exerts a tensional force. This dif-
ference in forces exerted on the tissue may explain the in-
creased growth capacity of the tissue in the perforated
chamber compared to tissue in the closed chamber, which
has no such connections and tends to retract, encapsulate,
and shut down the proliferative process. Because the fat flap
on the epigastric pedicle was raised in the axis of the milk
line and a percentage of the tissue (average 5.2%) comprised
breast ducts, morphometric analysis of the newly grown
tissue showed that volume of breast tissue increased pro-
portionally. This would suggest that the phenomenon ob-
served in these chambers is not primarily an adipogenic
response, but a global growth stimulus, in this case, growth
of fat, blood vessels, and breast. It may be that this is a
model for autologous tissue growth and has much wider
generic applications.
This model differs from the chamber model we previ-
ously reported14 in that rather than an arteriovenous (AV)
shunt forming the basis of the chamber vasculature we have
inserted a ligated pedicle. The use of an attached fat flap,
which was not recognized at the time of our previous study,
is a novel and potentially useful method to produce new
tissue, and shows potential for expansion of existing living
tissues in the chamber space. Unlike the muscle graft, which
was dead, the flap is living and cells from the flap are pro-
liferating in response to the chamber environment and pro-
ducing more fat.
The use of the PLGA scaffolds did not result in a volume
increase of adipose tissue in this study. This may be due to
the small internal pore sizes of the scaffolds used,52 as it
appears that the new fat tissue was unable to expand into the
PLGA. However, for tissue engineering, a biodegradable
scaffold matrix of defined size, shape, material, and struc-
ture is theoretically advantageous to allow the cells to in-
vade, differentiate, and proliferate. It is important that the
scaffold is mechanically stable and the carrier is not re-
sorbed too quickly. It is possible that the main function of a
scaffold is to simply maintain a space to permit newly
growing tissue to advance. In our model, the rigid cham-
ber shell served this function, and constructs placed in the
animal without the chamber surrounding them were sig-
nificantly smaller than those with chambers, especially per-
forated ones. This suggests that the chambers did provide
protection against compression and strain. We were also
using a fat flap with an inherent structure and a vascular
supply already in place, reducing the need for the structural
support role of a scaffold; however, in group 2 (without a
chamber and without a scaffold) the tissue failed to grow.
The 3D structure of the scaffold is also important for the
deposition of extracellular matrix53 to achieve properties
similar to those of the native tissue. PLGA polymer23,54 and
hyaluronic acid based scaffolds55 were evaluated as matri-
ces for the growth and differentiation of rat and human
preadipocytes and adipose cells. However, only small vol-
umes of fat tissue were produced.
One of the limitations of this work is the short-term
evaluation, to only 6weeks, and to address this issue a con-
current long-term study is in progress. However, histologi-
cal evaluation showed not only increased adipocyte cell
numbers but also essentially normal fat tissue architecture,
including a normal and uniform vascular density, which is
essential for continuing nutrition of the newly proliferating
cells. Lack of vascularity seems to be the common enemy of
previous cell implantation techniques.Histologyalso showed
no evidence of any inflammatory response in the non-PLGA
groups, and this could be expected to be advantageous to
longer term survival.
We have demonstrated for the first time that large vol-
umes of vascularized mature adipose tissue based on a vas-
cular pedicle can be engineered, without requiring complex
and difficult-to-deliver exogenous angiogenic and adipo-
genic growth factors. Also, there is no need for an extra-
cellular biological matrix support, nor are any beneficial
effects observed with biodegradable scaffolds. Signifi-
cantly, the dissection of the vascularized adipose tissue flap
is similar to that of human flaps56,57 and has clear clinical
potential. Thus, the approach pursued in this study may be
helpful for the reconstruction of soft-tissue defects after
complex trauma or oncological resection as well as for non-
implant breast reconstruction. Indeed, the chamber model
may have much wider applications as a generic method of
stimulating spontaneous growth of many different tissue
types, including organ growth. The mechanisms of fat
growth may have parallels with obesity and serve as useful
research tools for studies in obesity and metabolic disorders.
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